CI Investments Inc’s iShares Biotechnology ETF IBB Stock Holding History

CI Investments Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,500	Closed	-$853K	–	1227
2022 Q4	$853K	Sell	6,500 -3,500	-35%	-$452K	﹤0.01%	384
2022 Q3	$1.17M	Sell	10,000 -2,500	-20%	-$310K	0.01%	367
2022 Q2	$1.47M	Buy	+12,500	New	+$1.48M	0.01%	358
2022 Q1	–	Sell	-483,648	Closed	-$73.8M	–	1364
2021 Q4	$73.8M	Buy	483,648 +105,727	+28%	+$16.4M	0.25%	106
2021 Q3	$61.1M	Sell	377,921 -10,000	-3%	-$1.68M	0.23%	115
2021 Q2	$63.5M	Hold	387,921	–	–	0.23%	113
2021 Q1	$58.4M	Buy	+387,921	New	+$61.6M	0.25%	114

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CI Investments Inc's IBB Position: Q1 2023 in Review

CI Investments Inc sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 6,500 shares — an estimated $853K sold.

CI Investments Inc first reported a position in IBB in Q1 2021 and held it in 7 quarters. The position peaked at $73.8M in Q4 2021. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

CI Investments Inc reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
CI Investments Inc sold 6,500 iShares Biotechnology ETF shares in Q1 2023, an estimated $853K.
CI Investments Inc first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 7 quarters.
CI Investments Inc's iShares Biotechnology ETF position peaked at $73.8M in Q4 2021.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on CI Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.